What are INDmoney investors doing with Lupin shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
+50%
Searches for Lupin on INDmoney have increased by 50% over the last 30 days.
Investment activity on INDmoney
+21.05%
Investment activity in Lupin among INDmoney users has increased by 21.05% over the last 30 days.
Among the most traded stocks
220th
Lupin was the 220th most traded stock on INDmoney over the last 7 days.
Average holding period of indmoney investors
31 days
INDmoney investors hold Lupin shares for an average of 31 days.
Key Events for Lupin
Lupin Stock Performance
as on November 20, 2026 at 9:31 pm IST
Day's Low
₹1,985.10₹2,014.00
1.43%
Downside
52 Week's Low
52 Week's High
₹1,892.90₹2,529.50
6.01%
Downside
25.60%
Upside

Lupin share price movements today
- Previous Close
- ₹1,998.80
- Open
- ₹1,992.00
- Volume
- 6.31L
- Upper Circuit
- ₹2,053.30
- Lower Circuit
- ₹1,933.70
- Day's Low - High
- ₹1,985.10 - ₹2,014.00
- 52 Week Low - High
- ₹1,892.90 - ₹2,529.50
Lupin Historical Returns
- 1 Month Return
- + 2.55 %
- 3 Month Return
- -8.53 %
- 1 Year Return
- -0.76 %
- 3 Year Return
- + 64.87 %
- 5 Year Return
- + 131.15 %
Lupin Fundamentals
as on November 20, 2026 at 4:01 pm IST
Market Cap
₹92,098.81 Cr
Return on Equity (ROE)
23.4
PE Ratio (TTM)
17.11
Return on capital employed (ROCE)
27.47
Industry PE ratio
53.91
Beta (LTM)
0.46
P/B Ratio
3.51
Dividend Yield
0.78
PEG Ratio
0.78
Quarterly Earnings Growth YOY
-22.19
EPS (TTM)
117.14
Book Value
490.99
Lupin Stock Valuation
as on November 20, 2026 at 4:01 pm IST
Lupin in the last 5 years
Lowest (-6437.86x)
December 3, 2018
Today (17.11x)
November 19, 2026
Industry (53.91x)
November 19, 2026
Highest (517.33x)
December 2, 2022
Today’s Price to Earnings Ratio: 17.11x
Lupin Technical Analysis
Track how Lupin technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 1.45 | |
CCI (20) | 19.53 | Neutral |
RSI (14) | 53.73 | Neutral |
Momentum (10) | 0 | Neutral |
ADI (14) | 55.04 | Neutral |
Ultimate Oscillator (7,14,28) | 85.33 | Bullish |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 1998.19 | |
EMA (20) | 1997.25 | Bullish |
VWMA (20) | 1998.6 | |
SMA (50) | 1993.06 | Bullish |
EMA (50) | 1994.88 | Bullish |
SMA (200) | 1997.4 | Bullish |
EMA (200) | 1995.15 | Bullish |
KAMA (200) | 1995.7 | Bullish |
DEMA (200) | 1995.05 | Bullish |
Lupin Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Lupin with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 92,098.81 | 26.23% | 0.63 | 5,355 | 27,958 | |
| BUY | 7,383.65 | -12.05% | 0.00 | 326 | 1,837 | |
| BUY | 1,03,510.48 | 37.33% | 0.60 | 3,502 | 33,653 | |
| BUY | 1,19,700.46 | 32.6% | 0.69 | 5,026 | 51,180 | |
| BUY | 56,365.63 | 7.19% | 0.00 | 1,414 | 6,445 |
Market expectation of Lupin Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
40.00%
Buy
31.43%
Hold
28.57%
Sell
Lupin Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Lupin Ltd Annual Profit & Loss
Figures in Rupees Crores
Lupin Ltd Cash Flow
Figures in Rupees Crores
Lupin Corporate Actions
View detailed summary of the earnings and dividend history of Lupin.
Lupin Ltd Earnings Results
Lupin Ltd’s net profit fell -21.83% since last year same period to ₹1,155.26Cr in the Q2 2026-2027. On a quarterly growth basis, Lupin Ltd has generated -18.36% fall in its net profits since last 3-months.
Read MoreLupin Ltd Dividends May,2026
In the quarter ending March 2026, Lupin Ltd has declared dividend of ₹18.00 per share on 07 May 2026 - translating a dividend yield of 0.90%.
Read More about Dividends
Indices Featuring Lupin Stock
Check stock indices that include Lupin.
Insights on Lupin Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise

In the last 7 days, LUPIN stock has moved up by 0.9%
POSITIVE IMPACTRetail Holding Up

Retail Investor have increased holdings from 6.08% to 6.09% in Sep 2026 quarter
POSITIVE IMPACTFII Holding Up

Foreign Institutions have increased holdings from 22.42% to 23.28% in Sep 2026 quarter
NO EFFECTAgainst Peers

In the last 1 year, Laurus Labs Ltd has given 133.6% return, outperforming this stock by 135.2%
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 46.85% of holdings in Sep 2026 quarter
NO EFFECTAgainst Peers

In the last 3 years, Laurus Labs Ltd has given 526.6% return, outperforming this stock by 459.8%
NEGATIVE IMPACTMF Holding Down

Mutual Funds have decreased holdings from 14.84% to 14.58% in Sep 2026 quarter
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 3 quarters, 1.46K Cr → 1.15K Cr (in ₹), with an average decrease of 10.7% per quarter
NEGATIVE IMPACTRevenue Fall

Revenue is down for the last 2 quarters, 8.40K Cr → 7.95K Cr (in ₹), with an average decrease of 5.4% per quarter
Lupin Stock Futures & Options Contracts
View the latest movement in Lupin Futures & Options, including strike prices, expiry dates, and percentage changes.
Lupin Options
Lupin Futures
About Lupin Ltd
The company's top products include a wide range of prescription and over-the-counter drugs, including antibiotics, cardiovascular medications, antidiabetics, and anti-asthmatics. Lupin Ltd also manufactures and markets a variety of branded products, including Metoject, Lupitac, and Lupizole. In addition, the company produces a number of popular generic drugs, such as Amlodipine, Montelukast, and Cetirizine.
Lupin Ltd is one of the world's leading manufacturers of APIs, with a portfolio that includes more than 200 APIs and intermediates. The company also produces a range of animal health products, such as veterinary vaccines, feed supplements, and pet care products.
Revenue: ₹7,785.52Cr as on September 2026 (Q2 FY27)
Net Profit: ₹1,155.30Cr as on September 2026 (Q2 FY27)
Listing date: 30 Nov, 1994
Chairperson Name: M D Gupta
| Organisation | Lupin Ltd |
| Industry | Pharmaceuticals |
| CEO | M D Gupta |
| E-voting on shares | Click here to vote |
FAQs
What is Lupin share price today?
Lupin share price today stands at ₹2014 as on at the close of the market. Lupin share today touched a day high of ₹2014 and a low of ₹1985.1.
What is the 52 week high and 52 week low range for Lupin share?
Lupin touched a 52 week high of ₹2529.5 and a 52 week low of ₹1892.9. Lupin share price today i.e. is closed at ₹2014, which is -20.38% down from its 52 week high and 6.40% up from its 52 week low.
What is Lupin's market capitalisation today?
Lupin market capitalisation is ₹92,098.81 Cr as on .
How to buy Lupin shares?
To buy Lupin shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for LUPIN or Lupin Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Lupin shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Lupin trading volume today?
Lupin trading volume is 6.31L as on . This means that 6.31L shares of Lupin were bought and sold on the stock market during today's trading session.
What are INDmoney investors doing with Lupin shares right now?
Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Lupin have both increased over the past 30 days, and the average INDmoney investor holds the stock for 31 days. This reflects platform activity only and is not investment advice.